Androgen receptor co-regulation in prostate cancer
Prostate cancer (PCa) progression relies on androgen receptor (AR) action. Preventing AR's ligand-activation is the frontline treatment for metastatic PCa. Androgen deprivation therapy (ADT) that inhibits AR ligand-binding initially induces remission but eventually fails, mainly because of adap...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | Asian Journal of Urology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214388219300980 |